Chilean and French work together on new formula to fight type-I diabetes

A Chilean research team directed by Alexis Kalergis, academic of UC and Millennium Institute on Immunology and Immunotherapy (IMII) director, is working since 10 years on an enzyme called Heme-Oxygenase-1 (HO-1). This molecule can counteract various autoimmune diseases, such as lupus and type-I diabetes. Researches expect to perform the first clinical assay in humans, thanks to an alliance with the the Institut National de la Santé et de la Recherche Médicale of France.


This note is published in La Tercera